We are live on ! Find out more
KT

Kevin Tang Portfolio holdings

AUM $783
1-Year Est. Return 75.59%
This Fund
S&P 500
This Quarter Est. Return
-4.06%
1 Year Est. Return
-75.59%
3 Year Est. Return
-70.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.24M
AUM Growth
-$53K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LJPC
1
DELISTED
La Jolla Pharmaceutical Company
LJPC
$967K 78.24%
240,000
– –
HRTX icon
2
Heron Therapeutics
HRTX
$86.9M
$269K 21.76%
18,158
– –

Similar funds

GM
Gilfoyle Management Branford, Connecticut $25K AUM
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Kevin Tang's Q3 2020 Portfolio in Review

As of Q3 2020, Kevin Tang held 2 positions worth $1.24M, down 4.1% from $1.29M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2020: portfolio turnover was 0%. Kevin Tang opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kevin Tang's ten largest holdings make up 100% of its $1.24M portfolio in Q3 2020.
  • Kevin Tang opened 0 new positions and closed 0 in Q3 2020.
  • Kevin Tang's portfolio value fell 4.1% quarter-over-quarter to $1.24M.

Based on Kevin Tang's 13F filing for Q3 2020, filed 16 Nov 2020.